UNASSIGNED: 189 Background: @entity5 treatment negatively affects @entity413 control and puts @entity1 at risk for hospital admissions. A one year medical record review at Lehigh Valley Hospital revealed that 75.4% of @entity6 @entity1 receiving treatment in the @entity5 center had at least one emergency department (ED) and/or inpatient (IP) admission-13.2% had a @entity6 code present among the top 3 discharge diagnoses. We implemented a program in which a certified @entity6 educator (CDE) and nurse practitioner worked with oncologists and primary care providers (PCP) to coordinate care for these @entity1 . METHODS: @entity5 @entity1 with @entity6 or treatment related @entity4854 were referred to the @entity6 Oncology Program for care management (CM). CM included @entity1 assessment, education, care plan development, collaboration with PCP, and follow-up during treatment. A clinical practice guideline was developed for infusion nurses to treat @entity4854 . @entity6 medications were modified during @entity5 treatment in collaboration with the PCP. CM ended at the conclusion of the course of treatment or with end of life care. Program evaluation consisted of @entity1 and provider surveys, and analysis of ED/IP admissions. RESULTS: In a preliminary analysis of 98 @entity1 that received CM, 74 ED/IP admissions occurred between the first appointment with the CDE and the end of CM; 11 admissions (14.8%) were for @entity6 or @entity4854 related diagnosis. At baseline, @entity1 mean FACT-G scores were slightly lower than published normative data for @entity5 @entity1 . Significant improvements from baseline to 2 months post program enrollment were found among @entity1 in @entity6 empowerment and satisfaction with @entity6 treatment scores. Provider survey responses at baseline found that PCPs are more satisfied with oncologist communication than oncologists are with PCP communication. Final results of the @entity1 and provider surveys and program impact on ED/IP admissions will be presented. CONCLUSIONS: @entity1 empowerment and satisfaction with treatment may be improved by focused @entity6 care management. Final data analyses will indicate if this improvement is achieved along with reductions in ED/IP admissions for @entity6 related diagnoses among @entity5 @entity1 .

@entity6 care management during XXXX treatment.

@entity1 :: ('9606', 'Species') :: ['participants', 'patients', 'participant', 'patient', 'Patient'] @entity6 :: ('MESH:D003920', 'Disease') :: ['Diabetes', 'diabetic', 'diabetes'] @entity5 :: ('MESH:D009369', 'Disease') :: ['cancer', 'Cancer'] @entity4854 :: ('MESH:D006943', 'Disease') :: ['hyperglycemia'] @entity413 :: ('MESH:D005947', 'Chemical') :: ['glucose']
@entity5 :: (MESH:D009369,Disease) :: ['cancer']
